3 versus 6 months of adjuvant oxaliplatin-fluoropyrimidine combination therapy for colorectal cancer (SCOT): an international, randomised, phase 3, non-inferiority trial-Reference-Cited by-同舟云学术

3 versus 6 months of adjuvant oxaliplatin-fluoropyrimidine combination therapy for colorectal cancer (SCOT): an international, randomised, phase 3, non-inferiority trial

Published:2018-04 Issue:4 Volume:19 Page:562-578
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Iveson Timothy J,Kerr Rachel S,Saunders Mark P,Cassidy Jim,Hollander Niels Henrik,Tabernero Josep,Haydon Andrew,Glimelius Bengt,Harkin Andrea,Allan Karen,McQueen John,Scudder Claire,Boyd Kathleen Anne,Briggs Andrew,Waterston Ashita,Medley Louise,Wilson Charles,Ellis Richard,Essapen Sharadah,Dhadda Amandeep S,Harrison Mark,Falk Stephen,Raouf Sherif,Rees Charlotte,Olesen Rene K,Propper David,Bridgewater John,Azzabi Ashraf,Farrugia David,Webb Andrew,Cunningham David,Hickish Tamas,Weaver Andrew,Gollins Simon,Wasan Harpreet S,Paul James

Publisher

Elsevier BV

Subject

Oncology

Reference28 articles.

1. GLOBOCAN 2012 v1.0, cancer incidence and mortality worldwide: IARC cancer base no. 11;Ferlay,2013

2. Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma;Moertel;N Engl J Med,1990

3. Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer;Andre;N Engl J Med,2004

4. Oxaliplatin combined with weekly bolus fluorouracil and leucovorin as surgical adjuvant chemotherapy for stage II and III colon cancer: results from NSABP C-07;Kuebler;J Clin Oncol,2007

5. Capecitabine plus oxaliplatin compared with fluorouracil and folinic acid as adjuvant therapy for stage III colon cancer;Haller;J Clin Oncol,2011

Cited by 143 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Validity of Patient-Reported Outcome Measures in Evaluating Nerve Damage Following Chemotherapy;JAMA Network Open;2024-08-09

2. The Causes Behind the Survival Paradox in Non-Metastatic Colorectal Cancer Patients and its Impact on the Treatment Regimen: A Retrospective Cohort Study;Surgery;2024-08

3. Time From Colorectal Cancer Surgery to Adjuvant Chemotherapy;JAMA Surgery;2024-08-01

4. Super-enhancers reorganization controls re-sensitization of oxaliplatin-resistant FBXW7-mutated colorectal cancer;2024-07-30

5. Accrual and statistical power failure in published adjuvant phase III oncology trials: a comprehensive analysis from 2013 to 2023;ESMO Open;2024-07